Table 2.
Factors associated with ablation in AF patients before PSM.
| Variables | Univariable analysis | Multivariable analysis | ||
|---|---|---|---|---|
| OR (95%CI) | P-value | OR (95%CI) | P-value | |
| Age | 0.94 (0.94–0.95) | <0.001 | 0.95 (0.94–0.96) | <0.001 |
| TSH | 0.96 (0.94–0.98) | <0.001 | 0.97 (0.95–0.99) | 0.044 |
| LAD | 0.92 (0.91–0.93) | <0.001 | 0.95 (0.94–0.97) | <0.001 |
| Male | 1.27 (1.16–1.39) | <0.001 | 1.08 (0.94–1.23) | 0.27 |
| HTN | 0.68 (0.62–0.74) | <0.001 | 1.08 (0.95–1.24) | 0.25 |
| CHD | 0.64 (0.58–0.70) | <0.001 | 0.91 (0.79–1.04) | 0.17 |
| HF | 0.26 (0.23–0.30) | <0.001 | 0.53 (0.44–0.64) | <0.001 |
| Stroke | 0.58 (0.50–0.68) | <0.001 | 0.89 (0.72–1.10) | 0.28 |
| PAD | 0.56 (0.38–0.82) | 0.003 | 0.56 (0.30–1.03) | 0.06 |
| T2DM | 0.73 (0.65–0.82) | <0.001 | 0.96 (0.82–1.13) | 0.63 |
| CKD | 0.27 (0.22–0.33) | <0.001 | 0.57 (0.43–0.74) | <0.001 |
| VTE | 0.34 (0.12–0.98) | 0.046 | 0.82 (0.24–2.74) | 0.74 |
| PeAF | 0.54 (0.49–0.59) | <0.001 | 0.81 (0.70–0.93) | 0.003 |
| Cancer | 0.59 (0.47–0.74) | <0.001 | 0.77 (0.56–1.05) | 0.10 |
Abbreviations: see Table 1; OR, odds ratio.